Articles

Articles | July 24, 2023
IQVIA’s Privacy Analytics Ranked amongst the Top 3 Data Masking Providers Worldwide for Second Year Running

Privacy Analytics (an IQVIA company) has been named a Top Three Data Masking Provider Worldwide for the second year running in Quadrant Knowledge Solutions’ 2022 Data Masking SPARK Matrix.
Articles | May 26, 2023
Will ChatGPT Put Data Sharing at Risk?

Large language models (LLMs) have emerged as transformative tools, reshaping the landscape of natural language processing and understanding.
Articles | May 11, 2023
4 Ways Organizations Can Think About Data Sharing

Here are four micro-stories showcasing how our clients are safely and effectively unlocking value from structured and unstructured data.
Articles | May 5, 2023
7 Effective Ways Providers and Payers Improve Healthcare with Sensitive Data

Here are seven micro-stories showcasing how our clients are safely and effectively unlocking value from structured and unstructured data.
Articles | May 4, 2023
Good Governance for Anonymized Data

Anonymized data can be a valuable resource for advancing research and achieving socially and organizationally beneficial outcomes.
Articles | May 1, 2023
7 Success Stories: How Health Tech & Analytics Companies Safely Harness Sensitive Data for Innovation

Here are seven micro-stories showcasing how our clients are safely and effectively unlocking value from structured and unstructured data.
Articles | August 4, 2022
Advancing Privacy-Enhancing Technologies

There is a tremendous opportunity to use data safely and responsibility to the benefit of people and society.
Articles | January 4, 2022
Are You Ready for the EU Clinical Trials Regulation?

Privacy Analytics’ Redaction-as-a-Service ensures fast, cost-effective clinical trial document submissions at scale
Articles | October 28, 2020
FPF Privacy and Pandemics Position Statement

We believe that data-driven insights are critical to addressing challenges introduced by the current pandemic, and that benefits can be realized while respecting privacy.
Articles | October 28, 2020
How anonymization can enrich every stage of the drug development lifecycle

I wrote in our September newsletter about how trial sponsors are well advised to view transparency as much more than just a box that has to be checked off.

Filter by Data Type

Categories